Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
PHASE2
This phase II clinical trial tests a chemotherapy regimen (dose-adjusted et...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma
PHASE1
This is a Phase 1b/2 randomized study of Iberdomide (CC-220) added to 3 dif...
To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)
PHASE1
This is an open-label, multicenter study to evaluate safety and tolerabilit...